Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease DOI Creative Commons
Angeliki Katsarou, Ioannis I. Moustakas, Iryna Pyrina

et al.

World Journal of Gastroenterology, Journal Year: 2020, Volume and Issue: 26(17), P. 1993 - 2011

Published: May 2, 2020

Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive storage of acids in the form triglycerides hepatocytes. It most prevalent western countries and includes a wide range clinical histopathological findings, namely from simple steatosis to steatohepatitis fibrosis, which may lead cirrhosis hepatocellular cancer. The key event for transition fibrosis activation quiescent hepatic stellate cells (qHSC) their differentiation myofibroblasts. Pattern recognition receptors (PRRs), expressed plethora immune cells, serve as essential components innate system whose function stimulate phagocytosis mediate inflammation upon binding them various molecules released damaged, apoptotic necrotic cells. PRRs on hepatocytes, Kupffer resident macrophages liver, other results production proinflammatory cytokines chemokines, well profibrotic factors microenvironment leading qHSC subsequent fibrogenesis. Thus, elucidation inflammatory pathways associated with pathogenesis progression NAFLD better understanding its pathophysiology new therapeutic approaches.

Language: Английский

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives DOI Creative Commons

Natascha Roehlen,

Émilie Crouchet,

Thomas F. Baumert

et al.

Cells, Journal Year: 2020, Volume and Issue: 9(4), P. 875 - 875

Published: April 3, 2020

Liver fibrosis due to viral or metabolic chronic liver diseases is a major challenge of global health. Correlating with disease progression, key factor for outcome and risk hepatocellular carcinoma (HCC). Despite different mechanism primary injury disease-specific cell responses, the progression fibrotic follows shared patterns across main etiologies. Scientific discoveries within last decade have transformed understanding mechanisms fibrosis. Removal elimination causative agent such as control cure infection has shown that reversible. However, reversal often occurs too slowly infrequent avoid life-threatening complications particularly in advanced Thus, there huge unmet medical need anti-fibrotic therapies prevent HCC development. while many candidate agents robust effects experimental animal models, their clinical trials been limited absent. no approved therapy exists In this review we summarize cellular drivers molecular fibrogenesis discuss impact development urgently needed therapies.

Language: Английский

Citations

852

Targeting TGF-β signal transduction for fibrosis and cancer therapy DOI Creative Commons
Dandan Peng,

Minyang Fu,

Manni Wang

et al.

Molecular Cancer, Journal Year: 2022, Volume and Issue: 21(1)

Published: April 23, 2022

Transforming growth factor β (TGF-β) has long been identified with its intensive involvement in early embryonic development and organogenesis, immune supervision, tissue repair, adult homeostasis. The role of TGF-β fibrosis cancer is complex sometimes even contradictory, exhibiting either inhibitory or promoting effects depending on the stage disease. Under pathological conditions, overexpressed causes epithelial-mesenchymal transition (EMT), extracellular matrix (ECM) deposition, cancer-associated fibroblast (CAF) formation, which leads to fibrotic disease, cancer. Given critical downstream molecules progression cancers, therapeutics targeting signaling appears be a promising strategy. However, due potential systemic cytotoxicity, lagged. In this review, we summarized biological process TGF-β, dual tumorigenesis, clinical application TGF-β-targeting therapies.

Language: Английский

Citations

571

Hepatic inflammatory responses in liver fibrosis DOI
Linda Hammerich, Frank Tacke

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2023, Volume and Issue: 20(10), P. 633 - 646

Published: July 3, 2023

Language: Английский

Citations

311

Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis DOI
Santosh Kumar,

Qihua Duan,

Rongxue Wu

et al.

Advanced Drug Delivery Reviews, Journal Year: 2021, Volume and Issue: 176, P. 113869 - 113869

Published: July 16, 2021

Language: Английский

Citations

226

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment DOI Creative Commons
Leen Heyens, Dana Busschots,

Ger H. Koek

et al.

Frontiers in Medicine, Journal Year: 2021, Volume and Issue: 8

Published: April 14, 2021

An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis steatohepatitis (NASH). NASH is a chronic state inflammation that leads the transformation hepatic stellate cells myofibroblasts. These produce extra-cellular matrix results in fibrosis. In normal situation, fibrogenesis wound healing process preserves tissue integrity. However, sustained and progressive fibrosis can become pathogenic. This takes many years often asymptomatic. Therefore, patients usually present themselves with end-stage e.g., cirrhosis, decompensated even hepatocellular carcinoma. Fibrosis has also been identified as most important predictor prognosis NAFLD. Currently, only minority be hence referred for treatment. not because largely asymptomatic, but due fact currently biopsy still golden standard accurate detection performing harbors some risks requires resources expertise, applicable every clinical setting unsuitable screening. Consequently, non-invasive diagnostic tools, mainly based on analysis blood other specimens imaging developed development. this review, we will first give an overview pathogenic mechanisms evolution serves basis subsequent discussion current future biomarkers anti-fibrotic drugs.

Language: Английский

Citations

163

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease DOI Creative Commons
Xiaoqin Wu, Xiude Fan, Tatsunori Miyata

et al.

Annual Review of Pathology Mechanisms of Disease, Journal Year: 2022, Volume and Issue: 18(1), P. 411 - 438

Published: Oct. 21, 2022

Alcohol-associated liver disease (ALD) is one of the major diseases arising from chronic alcohol consumption and most common causes liver-related morbidity mortality. ALD includes asymptomatic steatosis, fibrosis, cirrhosis, alcohol-associated hepatitis its complications. The progression involves complex cell-cell organ-organ interactions. We focus on impact dysregulation homeostatic mechanisms regulation injury repair in liver. In particular, we discuss recent advances understanding disruption balance between programmed cell death prosurvival pathways, such as autophagy membrane trafficking, pathogenesis ALD. also summarize current innate immune responses, sinusoidal endothelial dysfunction hepatic stellate activation, gut-liver adipose-liver cross talk response to ethanol. addition,we describe potential therapeutic targets clinical trials aimed at alleviating hepatocyte injury, reducing inflammatory targeting gut microbiota, for treatment

Language: Английский

Citations

153

Diabetic fibrosis DOI Creative Commons
Izabela Tuleta, Nikolaos G. Frangogiannis

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal Year: 2020, Volume and Issue: 1867(4), P. 166044 - 166044

Published: Dec. 28, 2020

Language: Английский

Citations

140

Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis DOI Creative Commons

Hyunsoo Rho,

Alexander R. Terry, Constantinos Chronis

et al.

Cell Metabolism, Journal Year: 2023, Volume and Issue: 35(8), P. 1406 - 1423.e8

Published: July 17, 2023

Language: Английский

Citations

126

Extracellular Matrix Remodeling in Chronic Liver Disease DOI Creative Commons
Cristina Ortiz, Robert Schierwagen, Liliana Schaefer

et al.

Current Tissue Microenvironment Reports, Journal Year: 2021, Volume and Issue: 2(3), P. 41 - 52

Published: July 23, 2021

Abstract Purpose of the Review This review aims to summarize current knowledge extracellular matrix remodeling during hepatic fibrosis. We discuss diverse interactions with cells and surrounding in liver fibrosis, focus on molecular pathways mechanisms that regulate remodeling. Recent Findings The not only provides structure support for cells, but also controls cell behavior by providing adhesion signals acting as a reservoir growth factors cytokines. Summary Hepatic fibrosis is characterized an excessive accumulation matrix. During fibrogenesis, natural process varies, resulting its components, mainly collagens. Signals released induce activation stellate which are major source most abundant myofibroblasts liver. Graphical abstract

Language: Английский

Citations

119

Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia DOI Creative Commons

Marisa R. Morrow,

Battsetseg Batchuluun, Jianhan Wu

et al.

Cell Metabolism, Journal Year: 2022, Volume and Issue: 34(6), P. 919 - 936.e8

Published: June 1, 2022

Language: Английский

Citations

112